Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec (Québec), Canada.
Atherosclerosis. 2012 Aug;223(2):359-64. doi: 10.1016/j.atherosclerosis.2012.05.016. Epub 2012 May 24.
It has been suggested that a reduced HDL particle size could be another feature of the atherogenic dyslipidemia found among viscerally obese subjects.
To investigate, in women, the relationship between HDL particle size and coronary artery disease (CAD).
Average HDL particle size was measured in a sample of 239 women on whom CAD was assessed by angiography.
Overall, women who had CAD were characterized by a deteriorated fasting metabolic risk profile, which was accompanied by smaller HDL particles compared to women without CAD (80.4 ± 2.2 Å vs. 81.5 ± 2.7 Å, p < 0.01). In addition, a reduced HDL particle size was a significant correlate of several features of the atherogenic metabolic profile of abdominal obesity such as increased triglyceride and apolipoprotein B concentrations, decreased HDL cholesterol levels, an elevated cholesterol/HDL cholesterol ratio and hyperinsulinemia and was also associated with an increased waist circumference (0.13≤|r|≤0.21, p < 0.05). Odds ratio of being affected by CAD was increased by 2.5-fold (95% CI: 1.4-4.5; p < 0.01) among women with smaller HDL particles compared to women with larger HDL particles. Finally, women characterized by the presence of the NCEP-ATP III clinical criteria or by hypertriglyceridemic waist were characterized by smaller HDL particles compared to women without these clinical phenotypes (p < 0.05).
HDL particle size appears to be another relevant feature of a dysmetabolic state which is related to CAD risk in women.
据认为,高密度脂蛋白颗粒小可能是内脏肥胖者存在动脉粥样硬化性血脂异常的另一个特征。
在女性中研究高密度脂蛋白颗粒大小与冠状动脉疾病(CAD)之间的关系。
对 239 名经血管造影评估 CAD 的女性进行平均 HDL 颗粒大小测量。
总体而言,患有 CAD 的女性具有恶化的空腹代谢风险特征,与无 CAD 的女性相比,其 HDL 颗粒较小(80.4±2.2Å 对 81.5±2.7Å,p<0.01)。此外,较小的 HDL 颗粒大小与腹部肥胖的致动脉粥样硬化代谢特征的多个特征密切相关,如甘油三酯和载脂蛋白 B 浓度增加、HDL 胆固醇水平降低、胆固醇/HDL 胆固醇比值升高和高胰岛素血症,并且还与腰围增加相关(0.13≤|r|≤0.21,p<0.05)。与 HDL 颗粒较大的女性相比,HDL 颗粒较小的女性患 CAD 的几率增加了 2.5 倍(95%可信区间:1.4-4.5;p<0.01)。与没有这些临床表型的女性相比,具有 NCEP-ATP III 临床标准或高甘油三酯腰围的女性的 HDL 颗粒较小(p<0.05)。
HDL 颗粒大小似乎是与 CAD 风险相关的代谢异常状态的另一个相关特征。